Drug Name: Terlivaz
Active Ingredient: terlipressin
Indications: To improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function
Approval Date: 9/14/2022
Company: Mallinckrodt Hospital Products Inc
Learn more: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022231s000lbl.pdf